Perspectives
perspectives
February 3rd, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
perspectives
January 27th, 2026
What Regulators Want to See in Surrogate Endpoints Today
perspectives
January 20th, 2026
Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration
perspectives
January 13th, 2026
Making Clinical Trial Technology Work in Practice
perspectives
December 16th, 2025
Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026
perspectives
December 9th, 2025
The Real Meaning of “Expedited” in Drug Development
perspectives
December 2nd, 2025
What AI Singularity Could Mean for the Future of Clinical Biometrics
perspectives
November 18th, 2025
The Role of AI in Transforming Medical Writing
perspectives
November 11th, 2025
A Leader’s Guide to Developing High-Performing Clinical Data Management Teams
perspectives
November 4th, 2025
4 Key Takeaways from the EMA - Health Canada Joint Review Process and Evaluation of Its Efficiency
perspectives
October 28th, 2025
New Updates on Clinical Trial Transparency and Regulatory Requirements: A Comprehensive Overview
perspectives
October 21st, 2025
Shaping Clinical Development Through Writing: Francesca’s Journey at MMS
